Pharmaceutical Supply – BISACODYL DELAYED-RELEASE TABLETS

The contract obligates the supply of FDA-approved bisacodyl delayed-release tablets in 1,000-count boxes, strictly compliant with the NDC code 00904-6407-61, for delivery to Fort Campbell, Kentucky. This is a subcontract issued under the Defense Logistics Agency, part of the Department of Defense, and falls under the NAICS code 325412 which designates pharmaceutical and botanical manufacturing. The goods must meet all regulatory standards for FDA approval and packaging requirements to ensure compatibility with military medical protocols. Delivery is intended to support healthcare operations at the specified military installation, and the contract was posted on July 15, 2026, indicating it is a forward-looking procurement. The award is linked to the DIBBS system under contract SPE2DX25D9900 and delivery order SPE2DP26F7711, with a total of 7,203 units accounted for in the award. While specific delivery timelines, pricing, and performance metrics are not detailed here, the structure implies adherence to federal supply schedules and defense procurement regulations. The place of performance is fixed at Fort Campbell, KY, and although no point of contact or exact address is provided, the transaction is managed through the Defense Logistics Agency’s procurement infrastructure. Compliance with NDC standards and regulatory approval is essential for acceptance and payment under this agreement.